• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Signal Transduct Target Ther . Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents

tetano

Editor, Senior Moderator
Signal Transduct Target Ther


. 2024 Jun 12;9(1):160.
doi: 10.1038/s41392-024-01876-3. Nonconserved epitopes dominate reverse preexisting T cell immunity in COVID-19 convalescents

Xin Wang[SUP] #[/SUP][SUP] 1 2 [/SUP], Jie Zhang[SUP] #[/SUP][SUP] 3 4 5 [/SUP], Maoshun Liu[SUP] 2 6 [/SUP], Yuanyuan Guo[SUP] 1 2 [/SUP], Peipei Guo[SUP] 1 2 [/SUP], Xiaonan Yang[SUP] 1 2 [/SUP], Bingli Shang[SUP] 2 6 [/SUP], Min Li[SUP] 2 [/SUP], Jinmin Tian[SUP] 2 7 [/SUP], Ting Zhang[SUP] 2 8 [/SUP], Xi Wang[SUP] 3 4 5 [/SUP], Ronghua Jin[SUP] 3 4 5 [/SUP], Jikun Zhou[SUP] 9 [/SUP], George F Gao[SUP] 10 11 12 [/SUP], Jun Liu[SUP] 13 14 [/SUP]



Affiliations
Abstract

The herd immunity against SARS-CoV-2 is continuously consolidated across the world during the ongoing pandemic. However, the potential function of the nonconserved epitopes in the reverse preexisting cross-reactivity induced by SARS-CoV-2 to other human coronaviruses is not well explored. In our research, we assessed T cell responses to both conserved and nonconserved peptides shared by SARS-CoV-2 and SARS-CoV, identifying cross-reactive CD8[SUP]+[/SUP] T cell epitopes using enzyme-linked immunospot and intracellular cytokine staining assays. Then, in vitro refolding and circular dichroism were performed to evaluate the thermal stability of the HLA/peptide complexes. Lastly, single-cell T cell receptor reservoir was analyzed based on tetramer staining. Here, we discovered that cross-reactive T cells targeting SARS-CoV were present in individuals who had recovered from COVID-19, and identified SARS-CoV-2 CD8[SUP]+[/SUP] T cell epitopes spanning the major structural antigens. T cell responses induced by the nonconserved peptides between SARS-CoV-2 and SARS-CoV were higher and played a dominant role in the cross-reactivity in COVID-19 convalescents. Cross-T cell reactivity was also observed within the identified series of CD8[SUP]+[/SUP] T cell epitopes. For representative immunodominant peptide pairs, although the HLA binding capacities for peptides from SARS-CoV-2 and SARS-CoV were similar, the TCR repertoires recognizing these peptides were distinct. Our results could provide beneficial information for the development of peptide-based universal vaccines against coronaviruses.


 
Back
Top Bottom